ACMR stock flirts with a fresh 52-week high as ACM Research nears Jan. 22 outlook update

ACMR stock flirts with a fresh 52-week high as ACM Research nears Jan. 22 outlook update

New York, Jan 5, 2026, 11:25 ET — Regular session

  • ACMR up about 1% in late morning trade after an intraday push toward $46
  • Company plans a Jan. 22 premarket update on preliminary 2025 revenue range and initial 2026 outlook
  • Chip equipment peers climb as the semiconductor group outperforms

Shares of ACM Research Inc rose 1.0% to $45.34 in late-morning trading after touching $46.02, putting the stock within sight of its highest level in a year. Over the past 52 weeks, ACMR has traded between $14.97 and $46.09.

The Fremont, California-based chip-equipment maker said it will release a preliminary revenue range for fiscal 2025 and provide its initial 2026 revenue outlook before U.S. markets open on Thursday, Jan. 22. ACM also said it will participate virtually in the Needham Growth Conference and host one-on-one meetings on Jan. 15. 1

That calendar matters now because the company’s update lands before its full results and can reset expectations for 2026 demand. Guidance — a company’s own forecast — often drives positioning in semiconductor tools, where order timing can shift with customer spending plans.

Semiconductor names were higher more broadly, with the iShares Semiconductor ETF up 2.6%, and larger toolmakers Applied Materials, Lam Research and KLA up roughly 6% to 7% in late morning trade.

The Needham Growth Conference runs Jan. 8–16 with a mix of virtual and in-person sessions, and investors often use it to probe for early signals on spending trends and product cycles. 2

In its last quarterly update in November, ACM reported third-quarter revenue of $269.2 million, up 32% from a year earlier, and narrowed its 2025 revenue guidance to $875 million to $925 million. “We grew revenue by 32%, and continue to innovate with world-class tools,” Chief Executive David Wang said in a statement. 3

For traders, the near-term question is whether the Jan. 22 preliminary revenue range comes in toward the top end of that band and whether the first 2026 outlook implies faster growth — or a pause — as customers digest prior capacity builds.

But a run toward a year-high can amplify the downside too. A cautious 2026 outlook, weaker-than-expected tool acceptances, or a sudden cooling in chip capital spending would test sentiment quickly.

Technically, the stock’s next hurdle sits around the $46 area after Monday’s early push. The day’s low around $44 marks the first level short-term traders tend to watch for support.

Stock Market Today

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

7 February 2026
Ashtead shares closed Friday at 4,936p, up 1.09%, after the company bought 88,872 shares under its repurchase program. The group is set to shift its primary listing to New York on March 2, pending court approval, and will be removed from the FTSE UK index the same day. Ashtead paid a half-year dividend of 37.5 U.S. cents per share on Friday.
Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

7 February 2026
Beazley shares closed flat at 1,236 pence Friday as BlackRock disclosed a 6.55% stake and Vanguard reported 5.02%. Wellington Management cut its holding below 5%. The disclosures follow Zurich Insurance’s possible takeover offer of up to 1,335 pence per share, with a Feb. 16 deadline for a firm bid.
Salesforce stock rises as RBC lifts price target, AI demand back in focus
Previous Story

Salesforce stock rises as RBC lifts price target, AI demand back in focus

Rocket Lab stock slips after rally as insider sale filing surfaces; Neutron timing in focus
Next Story

Rocket Lab stock slips after rally as insider sale filing surfaces; Neutron timing in focus

Go toTop